Brief: MEI Pharma Reports Second Quarter Fiscal Year 2023 Results
09/02/2023 21:44
Feb 9 (Reuters) - MEI Pharma Inc MEIP.O :
* MEI PHARMA REPORTS SECOND QUARTER FISCAL YEAR 2023 RESULTS
AND
OPERATIONAL HIGHLIGHTS
* AS OF DECEMBER 31, 2022, CO HAD $124.2 MILLION IN CASH,
CASH
EQUIVALENTS, AND SHORT-TERM INVESTMENTS WITH NO OUTSTANDING DEBT
* QTRLY NET INCOME WAS $10.3 MILLION, OR $0.08 PER SHARE
* Q2 EARNINGS PER SHARE VIEW $-0.15 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw1bdjDja
Further company coverage: MEIP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations